Share on StockTwits
Join our smart investors - Get the best stock directories in  blockchain, cannabis, crypto, AI, IoT, cleantech. Daily podcasts in cannabis and crpto. Just $99  a year

Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSX: $ACB.TO, NASDAQ: $CRON, TSX: $APH.TO, CSE: $MTEC.C, TSXV: $N.V podcasts

Delta, Kelowna, BC - September 4, 2018 ( Newswire), a global news source covering leading sectors including marijuana and hemp stocks and its "potcast" site, release today's edition of its series, potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSX: $ACB.TO, NASDAQ: $CRON, TSX: $APH.TO, CSE: $MTEC.C, TSXV: $N.V

Transcript of Today's Podcast

Good morning and welcome to another potcast - looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today we will be looking at announcements from Aurora Cannabis Inc. trading on the TSX as ACB and the OTCQB as ACBFF, Cronos Group Inc. trading on the NASDAQ and TSX as CRON, Aphria Inc. trading on the TSX as APH OTC as APHQF, Cannvas MedTech Inc. trading on the CSE as MTEC and Namaste Technologies Inc. trading on the TSX-Venture as N.

Aurora Cannabis Inc. today announced that it has closed its previously announced debt facility with the Bank of Montreal ("BMO"). The facility consists of a $150 million term loan and a $50 million revolving credit facility, both of which mature in 2021. Included in the facility is an option to upsize the facility to $250 million total following the implementation of Bill C-45 on October 17, 2018, subject to agreement by BMO and satisfaction of certain legal and business conditions.

The debt facility is primarily secured by Aurora's production facilities, including Aurora Sky, Aurora Mountain, and Aurora Vie. Strategically located at Edmonton International Airport, Aurora Sky is the world's most technologically advanced cannabis facility, projected to produce in excess of 100,000 kg per year of high-quality, low-cost per gram, cannabis upon completion.

Today, Cronos Group Inc., a geographically diversified and vertically integrated cannabis group, and Ginkgo Bioworks Inc., the organism company, announced a landmark partnership to produce cultured cannabinoids. Using its platform technology for organism design and development, Ginkgo will complement Cronos Group's technologies for producing a full spectrum of cannabinoids. As part of this unprecedented deal, Cronos Group has agreed to issue a specific number of common shares in tranches subject to Ginkgo's achievement of certain production milestones.

As two of the leading companies in their respective industries, Cronos Group and Ginkgo believe that they are best-suited to unlock the potential of innovation in the cannabis industry. Cronos Group brings a deep understanding of the plant's biological structure and function, while Ginkgo brings 10 years of experience designing microorganisms for the production of cultured products across pharmaceuticals, agriculture, flavors, fragrances, and more.

Cannabinoids span a range of molecules with different properties, and ongoing research has demonstrated potential medicinal uses for indications such as chronic pain, nervous disorders, nausea, weight loss, and some mental illnesses. However, many pharmaceutically relevant cannabinoids are present only at very low quantities in the cannabis plant, making them economically impractical, difficult or impossible to extract at high purity and scale. The landmark partnership between Cronos Group and Ginkgo will leverage the expertise of both organizations to solve this challenge and make more accessible the benefits of cannabinoids in an economically sustainable way.

Aphria Inc. today announced that it has entered into a strategic partnership with Schroll Medical, a subsidiary of prominent European flower producer, Schroll Flowers. The Partnership will pursue the cultivation and worldwide distribution of organic, EU GMP-certified medical cannabis, and will be managed by the Company's wholly-owned subsidiary Aphria Deutschland GmbH ("Aphria Germany"). The deal accelerates Aphria's global expansion, in collaboration with an established and world-class partner, with first product expected to be available by early 2019.

In exchange for a 15% interest in the Partnership, Aphria is providing €100,000 to the Partnership, its leadership in cannabis greenhouse cultivation and experience in processing and worldwide distribution. This will include, but is not limited to, consulting on GMP certification, cannabis genetics and strains, and proprietary growing IP. Aphria will also handle the worldwide distribution of medical cannabis produced by the Partnership, which is anticipated to be made available to markets in Germany, Luxembourg, Switzerland and other developing medical cannabis markets. As part of the deal, Aphria maintains a path to increase its ownership interest to 50% and a path to realize full liquidity, each under certain conditions.

Cannvas MedTech Inc., a leading business technology company in the cannabis space, is pleased to announce its vendor of choice for integration to its Artificial Intelligence (A.I) component powering the cannabis education platform.

IBM Watson has been chosen to power the A.I. analytics branch of the Cannvas platform. It will serve as a best-in-class integrated solution most relevant and attuned for the persona-driven architecture of the platform. Leveraging IBMs A.I. service allows the Cannvas team to quickly analyze through the copious amounts of data attributes comprising the platform in a relevant and real-time fashion for its user base.

Deriving industry and customer insights in a real-time fashion for the CRM program requires the use of technologies that are at the leading edge of their space. Utilizing IBM Watsons capabilities allows the Cannvas technology stack to achieve this goal. takes the traditional Email Customer Journey and transforms it into a true Omni-Channel approach where user preferences and insights are utilized to serve a fully personalized message experience through the channel of their choice. will be able to truly embrace the concept of Omni-Channel marketing.

Namaste Technologies Inc. announced that the Company has signed a veteran patient services agreement and a medical cannabis supply agreement with Breton CannaPharms Ltd. Breton CannaPharms has a very strong presence in veteran communities across Canada and the entire management team has extensive experience in holistically servicing veterans and educating communities on the positive and misunderstood effects of medical cannabis to treat veterans suffering from both chronic pain and post-traumatic stress disorder ("PTSD").

Under the terms of the Patient Services Agreement, Breton Farms will work exclusively with NamasteMD to target patient acquisition within veteran groups across the country. Namaste is proud to partner with Breton Cannabis to focus on acquiring veteran patients and servicing their needs through its Access to Cannabis for Medical Purposes Regulations ("ACMRP") Licensed Producer partners. NamasteMD provides convenient access to nurse practitioners for medical consultations through online video and is available on the Apple Store, Google Play devices and online at

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, iHeartradio, Spreaker and Tunein.

If you would like to be a guest or sponsor this podcast contact

Investor ideas reminds all listeners to read our disclaimers and disclosures on the website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

Sign up to get the news alerts including the daily podcast and transcript for Investor ideas potcasts

Subscribe to the new cannabis podcast series:

Or visit


To hear more podcasts visit: podcasts are also available on iTunes, Google Play Music, Stitcher and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About - News that Inspires Big Investing Ideas is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from with our news alerts, articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the Stock Guru daily podcast on Support and Resistance Trading.

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info:

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: Global investors must adhere to regulations of each country.

Please read privacy policy:

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at

Follow us on Social Media



Do you trade or invest in Marijuana / Hemp Stocks? Check out our stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks

Join our Group on Linkedin and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing